Cell2location: mapping fine-grained cell types in spatial transcriptomics
Cell2location is a Bayesian model that resolves fine-grained cell types in spatial transcriptomics data by accounting for technical variation and sharing information across locations. Applied to three tissues, it revealed regional astrocyte subtypes in mouse brain, a rare pre-germinal center B cell population in human lymph node, and fine immune populations in human gut lymphoid follicles. Caveat: the reported results are biological findings from the method's application, with no single quantitative accuracy figure confirmed in the abstract.
Technology: Cell2location (Bayesian deep probabilistic model)
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: Cell2location was assessed in three tissues (mouse brain, human lymph node, human gut) and reported to give higher sensitivity and resolution than existing tools.
- Still unknown: The abstract names no conditions under which the claimed higher sensitivity holds and no limitations.
- AI role: A Bayesian model that resolves fine-grained cell types in spatial transcriptomics data.
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41587-021-01139-4&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 1414 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.